Request for COVID Vaccine Prioritization

Life Science Washington submitted the letter below to theWashington Department of Health requesting that two groups of high-risk essential life science employees be prioritized for early access to COVID-19 vaccines.  Our letter is consistent with BIO and AdvaMed requests for prioritization in the CDC’s Advisory Council on Immunization Practices (ACIP) framework.

Access the letter here.

Posted on Updated:
Share:
Related Resources
  • Industry Reports
  • 2025

Washington State Life Science Investment Report – July 2025
  • Policy Blog
  • 2025

Policy Blog – August 29, 2025 – Fighting for Research: Keeping NIH and Startup Funding Strong

Life Science Washington member companies know that discoveries happening in our state today will shape the cures of tomorrow. That progress depends on steady support from programs like the National Institutes of Health (NIH) and the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. We are working with our sibling state […]
  • Industry Reports
  • 2025

Washington State Life Science Investment Report – June 2025
  • Industry Reports
  • 2025

US Life Sciences Property Report – June 2025 – JLL